IRIS UniCatt

Galli, Mattia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.025
AS - Asia 1.475
EU - Europa 1.102
SA - Sud America 279
AF - Africa 39
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.933
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.980
SG - Singapore 710
CN - Cina 270
SE - Svezia 260
BR - Brasile 223
IT - Italia 200
VN - Vietnam 184
FR - Francia 150
DE - Germania 139
IE - Irlanda 75
IN - India 52
JP - Giappone 51
GB - Regno Unito 50
ID - Indonesia 50
FI - Finlandia 47
PL - Polonia 46
HK - Hong Kong 42
RU - Federazione Russa 33
CA - Canada 23
IQ - Iraq 22
UA - Ucraina 21
AR - Argentina 19
NL - Olanda 19
BD - Bangladesh 17
MX - Messico 15
AT - Austria 12
CZ - Repubblica Ceca 11
ET - Etiopia 11
AU - Australia 9
CI - Costa d'Avorio 9
IR - Iran 9
CO - Colombia 8
KR - Corea 8
PK - Pakistan 8
TR - Turchia 8
VE - Venezuela 8
ZA - Sudafrica 7
BE - Belgio 6
LT - Lituania 6
AZ - Azerbaigian 5
EC - Ecuador 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CH - Svizzera 4
ES - Italia 4
IL - Israele 4
JO - Giordania 4
QA - Qatar 4
UY - Uruguay 4
CL - Cile 3
EG - Egitto 3
EU - Europa 3
MA - Marocco 3
NP - Nepal 3
PT - Portogallo 3
SA - Arabia Saudita 3
TW - Taiwan 3
UZ - Uzbekistan 3
AL - Albania 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
MY - Malesia 2
PH - Filippine 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SO - Somalia 1
SR - Suriname 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.933
Salva come PNG Salva come JPEG
Città #
Singapore 390
Chandler 319
San Jose 182
Ashburn 179
New York 97
Beijing 86
Dublin 74
Ho Chi Minh City 64
Los Angeles 53
Jakarta 47
Hanoi 44
Lauterbourg 42
Warsaw 42
Tokyo 41
The Dalles 40
Milan 38
San Mateo 37
Princeton 35
Hong Kong 34
Boston 33
Rome 33
Helsinki 31
Wilmington 31
Bremen 29
Dallas 28
Marseille 28
Frankfurt am Main 24
Moscow 23
Hefei 22
Munich 22
São Paulo 22
Fairfield 18
Redwood City 18
Cattolica 17
Baghdad 15
Chicago 15
Woodbridge 15
Augusta 13
Paris 13
Atlanta 12
St Louis 12
Da Nang 11
Houston 11
Seattle 11
Dearborn 10
Haiphong 10
Pune 10
Turku 10
Abidjan 9
Jacksonville 9
London 9
North Bergen 9
Orem 9
Brooklyn 8
Buffalo 8
Denver 8
Düsseldorf 8
Falkenstein 8
Rio de Janeiro 8
Santa Clara 8
Seoul 8
Amsterdam 7
Montreal 7
Nuremberg 7
Roubaix 7
Saint Louis 7
Stockholm 7
Vienna 7
Belo Horizonte 6
Brasília 6
Brussels 6
Florence 6
Groningen 6
Kent 6
Lappeenranta 6
Mumbai 6
Naples 6
Washington 6
Ann Arbor 5
Asunción 5
Baku 5
Boardman 5
Brno 5
Curitiba 5
Dhaka 5
Guangzhou 5
Hyderabad 5
Leawood 5
Nanjing 5
Orangeburg 5
Phoenix 5
Poplar 5
San Francisco 5
Tukwila 5
Amman 4
Andover 4
Cambridge 4
Catania 4
Chennai 4
City of London 4
Totale 2.713
Salva come PNG Salva come JPEG
Nome #
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 236
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 178
Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials 169
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 167
Sex-Related Differences in Dilated Cardiomyopathy with a Focus on Cardiac Dysfunction in Oncology 161
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 154
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 141
Oral anticoagulants in fragile patients with percutaneous endoscopic gastrostomy and atrial fibrillation: the ORIGAMI pilot investigation 138
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) study 136
Comprehensive functional and anatomic assessment of myocardial bridging: Unlocking the Gordian Knot 131
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 128
Where Does Inflammation Fit? 125
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysis 124
Dual quantitative coronary angiography accurately quantifies intracoronary thrombotic burden in patients with acute coronary syndrome: Comparison with optical coherence tomography imaging 123
A 3-Year Single Center Experience With Left Atrial Pressure Remote Monitoring: The Long and Winding Road 122
Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of STEMI 121
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials 118
Device-based remote monitoring strategies for congestion-guided management of patients with heart failure: a systematic review and meta-analysis 117
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) with vs without left ventricular unloading by Impella: a systematic review and meta-analysis 117
Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction 117
Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome? 116
Experience of Remote Cardiac Care during Covid-19 Pandemic: the V-LAP™ device in advanced heart failure 114
Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: A systematic review and meta-analysis 114
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations 113
Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients 109
Neoatherosclerosis after drug-eluting stent implantation: A novel clinical and therapeutic challenge 101
Pre-stenting residual thrombotic volume assessed by dual quantitative coronary angiography predicts microvascular obstruction in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 100
Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond 100
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis 96
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials 95
Efficacy and safety of dual pathway inhibition in patients with cardiovascular disease: a systematic review and Meta-analysis 95
Sustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy 94
Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underling possible safety concerns 94
How deep is your lesion? Extreme guideliner V3 intubation through RIMA graft to treat a distal left anterior descending artery stenosis 92
Response - Letter to the editor: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: A pooled analysis underlying possible safety concerns 90
Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: Not a matter of faith 90
Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: A jump with a weak parachute? 88
Early anticoagulation in the current management of NSTE-ACS: Evidence, guidelines, practice and perspectives 82
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? 78
Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? 76
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 71
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal 68
Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation–ACS/PCI Trials 50
Aspirin in primary prevention of cardiovascular disease in the elderly 46
Totale 4.995
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.119
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022393 25 11 0 31 12 7 6 45 20 22 152 62
2022/2023921 102 108 65 143 47 124 56 80 136 10 29 21
2023/2024476 20 112 17 55 23 71 45 17 8 20 44 44
2024/2025816 19 14 68 44 65 46 28 39 113 98 165 117
2025/20262.072 349 34 96 233 404 84 417 102 147 131 53 22
Totale 4.995